Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma

NCT05922501 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Cancer
Refractory Multiple Myeloma
Multiple Myeloma

Interventions

DRUG: Isatuximab
DRUG: Belantamab mafodotin
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]